Current status of platelet manufacturing in 3D or bioreactors
- PMID: 37294031
- DOI: 10.1002/btpr.3364
Current status of platelet manufacturing in 3D or bioreactors
Abstract
Blood shortages for transfusion are global issues of grave concern. As in vitro manufactured platelets are promising substitutes for blood donation, recent research has shown progresses including different cell sources, different bioreactors, and three-dimensional materials. The first-in-human clinical trial of cultured platelets using induced pluripotent stem cell-derived platelets began in Japan and demonstrated its quality, safety, and efficacy. A novel bioreactor with fluid motion for platelet production has been reported. Herein, we discuss various cell sources for blood cell production, recent advances in manufacturing processes, and clinical applications of cultured blood.
Keywords: bioreactors; cell culture technology; immortalized; platelets.
© 2023 American Institute of Chemical Engineers.
References
REFERENCES
-
- Stein DM, Upperman JS, Livingston DH, et al. National blood shortage: a call to action from the trauma community. J Trauma Acute Care Surg. 2022;93(3):e119-e122. doi:10.1097/TA.0000000000003715
-
- McGann PT, Weyand AC. Lessons learned from the COVID-19 pandemic blood supply crisis. J Hosp Med. 2022;17(7):574-576. doi:10.1002/jhm.12843
-
- Liu H, Liu J, Wang L, Zhu F. In vitro generation of megakaryocytes and platelets. Front Cell Dev Biol. 2021;9:2252.
-
- Martínez-Botía P, Acebes-Huerta A, Seghatchian J, Gutiérrez L. In vitro platelet production for transfusion purposes: where are we now? Transfus Apher Sci. 2020;59(4):102864.
-
- Yang J, Luan J, Shen Y, Chen B. Developments in the production of platelets from stem cells. Mol Med Rep. 2021;23(1):1.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
